Join SFOG and Axitan for an exclusive webinar on December 7 at 2:00 p.m. ET to learn more.
Axitan’s FORC3® patent enters regional phase
Axitan’s patent application associated with its lead product FORC3®, with priority filing in Jan. 2019 (GB1901364.8) and PCT filing in Jan. 2020 (WO2020157519A1), have all now progressed into selected national and regional phases. Selected entries into the United States (US20220290114A1), European Union (EP3918061A1), Brazil (BR112021015059A2), and China (CN113677794A) reflect Axitan’s global ambitions and the markets it aims to develop. Axitan expects patent grant approvals in 2023.